Search research articles
Contact Us
Filters
Showing results (31-40 of 338) with videos related to
Page
of 34
Sort By:
Dialogues in Clinical Neuroscience
|
October 21, 2016
Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
Anna C Need, David B Goldstein
Molecular Genetics & Genomic Medicine
|
November 14, 2022
Using reported pathogenic variants to identify therapeutic opportunities for genetic diseases
Andrew K Ressler, David B Goldstein
Nature
|
October 28, 2005
Genomics: understanding human diversity
David B Goldstein, Gianpiero L Cavalleri
Dialogues in Clinical Neuroscience
|
April 9, 2010
Whole genome association studies in complex diseases: where do we stand?
Anna C Need, David B Goldstein
Current Neurology and Neuroscience Reports
|
August 31, 2015
Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies
Ryan S Dhindsa, David B Goldstein
Current Biology : CB
|
January 16, 2003
Demography, recombination hotspot intensity, and the block structure of linkage disequilibrium
Michael P H Stumpf, David B Goldstein
Trends in Biotechnology
|
May 20, 2015
Academic-industrial partnerships in drug discovery in the age of genomics
Tim Harris, Stelios Papadopoulos, David B Goldstein
Nature
|
April 16, 2010
Genomics: Lessons in complexity from yeast
David B Goldstein, Mohamed A F Noor
Nature Reviews. Drug Discovery
|
December 9, 2017
Drug development in the era of precision medicine
Sarah A Dugger, Adam Platt, David B Goldstein
Hepatology (Baltimore, Md.)
|
April 19, 2012
Introduction to the genetics and biology of interleukin-28B
Thomas Urban, Michael R Charlton, David B Goldstein
Page
of 34
Search research articles
Search
Showing results (31-40 of 338) with videos related to
Sort By:
Page
of 34
Dialogues in Clinical Neuroscience
|
October 21, 2016
Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
Anna C Need, David B Goldstein
Molecular Genetics & Genomic Medicine
|
November 14, 2022
Using reported pathogenic variants to identify therapeutic opportunities for genetic diseases
Andrew K Ressler, David B Goldstein
Nature
|
October 28, 2005
Genomics: understanding human diversity
David B Goldstein, Gianpiero L Cavalleri
Dialogues in Clinical Neuroscience
|
April 9, 2010
Whole genome association studies in complex diseases: where do we stand?
Anna C Need, David B Goldstein
Current Neurology and Neuroscience Reports
|
August 31, 2015
Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies
Ryan S Dhindsa, David B Goldstein
Current Biology : CB
|
January 16, 2003
Demography, recombination hotspot intensity, and the block structure of linkage disequilibrium
Michael P H Stumpf, David B Goldstein
Trends in Biotechnology
|
May 20, 2015
Academic-industrial partnerships in drug discovery in the age of genomics
Tim Harris, Stelios Papadopoulos, David B Goldstein
Nature
|
April 16, 2010
Genomics: Lessons in complexity from yeast
David B Goldstein, Mohamed A F Noor
Nature Reviews. Drug Discovery
|
December 9, 2017
Drug development in the era of precision medicine
Sarah A Dugger, Adam Platt, David B Goldstein
Hepatology (Baltimore, Md.)
|
April 19, 2012
Introduction to the genetics and biology of interleukin-28B
Thomas Urban, Michael R Charlton, David B Goldstein
Page
of 34